Tag - Clinical Prior Authorization Criteria

Provider Alert!

Provider Alert! Updated Clinical Prior Authorizations Criteria Guides

Date: September 8, 2023 Attention: All Providers Effective Date: July 31, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that the Texas Health and Human Services (HHSC) updated multiple clinical prior authorization criteria guides effective July 31, 2023. How this impacts providers: HHSC updated the following clinical prior authorization criteria guides with the noted changes: Anxiolytics/Sedatives/Hypnotics (ASH) Ramelteon Corrected step 4 in the Ramelteon criteria logic and diagram. Diazepam Added GCNs for diazepam (45092, 14210) to the prior authorization table Cytokine...

Provider Alert!

Provider Alert! Clinical Prior Authorization Criteria Revisions for Bylvay Scheduled for Nov. 21

Date: November 2, 2022 Attention: Providers Effective Date: November 21, 2022 Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event.  TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Texas Children’s Health Plan (TCHP) will revise clinical prior authorization criteria for Bylvay. The new prior authorization (PA) criteria will be effective November 21, 2022. TCHP will...